CoronaVac

Hong Kong: Despite low absolute risk, there is an increased relative risk of carditis a type of heart inflammation associated with Covid vaccine developed by US drugmaker Pfizer and China's CoronaVac, researchers have found. The…
Read More...

Beijing: A Chinese vaccine candidate -- CoronaVac -- appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years in an early-phase randomised clinical trial, say researchers. According to the study, published…
Read More...

Beijing: Chinese vaccine maker Sinovac has said that its Covid-19 vaccine candidate, CoronaVac, has been found to induce immune response in initial human trials. No severe adverse events were reported in either the phase-1 or phase-2…
Read More...